FDA panel approves new drug for diabetes
(USA TODAY) —- A Food and Drug Administration panel has reccommended approval of a new drug for Type 2 diabetes.
The drug contains canagliflozin, which lowers blood sugar by causing it to be excreted in urine.
Patients taking the drug may lose weight, however may temporarily increase the risk for stroke and heart attacks.
Source: USA TODAY